Abstract
Patients admitted to hospital with influenza B and A in Jerusalem, Israel, during the 2015-2016 and 2017-2018 influenza seasons demonstrated similar rates of intensive care unit (ICU) admission and associated disease severity. Most (63%) influenza B ICU patients received influenza B-mismatched trivalent vaccine. These findings call into question the equivalence of trivalent and quadrivalent vaccines in preventing severe influenza B.
Original language | English |
---|---|
Pages (from-to) | 1049-1052 |
Number of pages | 4 |
Journal | Clinical Infectious Diseases |
Volume | 69 |
Issue number | 6 |
DOIs | |
State | Published - 30 Aug 2019 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2019 The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.
Keywords
- influenza B
- influenza vaccine
- intensive care admission
- quadrivalent influenza vaccine
- trivalent influenza vaccine